Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ginsenoside-rh2
1. 78214-33-2
2. 20(s)-ginsenoside Rh2
3. (20s)-ginsenoside Rh2
4. 20(s)-ginsenoside
5. Ginsenoside-rh2
6. Chebi:77147
7. 20s-ginsenoside Rh2
8. 0ju44a5kwg
9. (2r,3r,4s,5s,6r)-2-[[(3s,5r,8r,9r,10r,12r,13r,14r,17s)-12-hydroxy-17-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
10. (20r)-ginsenoside Rh2
11. 20(s)-rh2
12. (3beta,12beta)-12,20-dihydroxydammar-24-en-3-yl Beta-d-glucopyranoside
13. (20r)ginsenoside Rh2
14. Ginsenosiderh2
15. 112246-15-8
16. (s)ginsenoside-rh2
17. 20s-ginsenosiderh2
18. Unii-0ju44a5kwg
19. Ginsenoside Rh2(s)
20. 20(s)- Ginsenoside Rh2
21. Ginsenoside 20-rh2
22. Chembl1783834
23. Dtxsid70999457
24. 67400-17-3
25. Hy-n0605
26. Bdbm50023457
27. Ginsenoside Rh2, Analytical Standard
28. Mfcd00800712
29. S9023
30. S9036
31. Zinc72129809
32. Akos037514675
33. Ccg-270259
34. Ccg-270261
35. Cs-3835
36. Ac-33940
37. Ginsenoside Rh2; 20(s)-ginsenoside Rh2
38. C22128
39. 20s-protopanaxdiol-3-o-beta-d- Glucopyranoside
40. 214g332
41. Q-100827
42. Q27146703
43. 3-o-.beta.-d-glucopyranosyl-20(s)-protopanaxadiol
44. 3beta-(beta-d-glucopyranosyloxy)dammar-24-ene-3beta,20beta-diol
45. Beta-d-glucopyranoside, (3beta,12beta)-12,20-dihydroxydammar-24-en-3-yl
46. .beta.-d-glucopyranoside, (3.beta.,12.beta.)-12,20-dihydroxydammar-24-en-3-yl
| Molecular Weight | 622.9 g/mol |
|---|---|
| Molecular Formula | C36H62O8 |
| XLogP3 | 5.6 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 7 |
| Exact Mass | 622.44446893 g/mol |
| Monoisotopic Mass | 622.44446893 g/mol |
| Topological Polar Surface Area | 140 Ų |
| Heavy Atom Count | 44 |
| Formal Charge | 0 |
| Complexity | 1070 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 15 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
19
PharmaCompass offers a list of Ginsenoside Rh2 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ginsenoside Rh2 manufacturer or Ginsenoside Rh2 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ginsenoside Rh2 manufacturer or Ginsenoside Rh2 supplier.
PharmaCompass also assists you with knowing the Ginsenoside Rh2 API Price utilized in the formulation of products. Ginsenoside Rh2 API Price is not always fixed or binding as the Ginsenoside Rh2 Price is obtained through a variety of data sources. The Ginsenoside Rh2 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ginsenoside Rh2 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ginsenoside Rh2, including repackagers and relabelers. The FDA regulates Ginsenoside Rh2 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ginsenoside Rh2 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ginsenoside Rh2 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ginsenoside Rh2 supplier is an individual or a company that provides Ginsenoside Rh2 active pharmaceutical ingredient (API) or Ginsenoside Rh2 finished formulations upon request. The Ginsenoside Rh2 suppliers may include Ginsenoside Rh2 API manufacturers, exporters, distributors and traders.
click here to find a list of Ginsenoside Rh2 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Ginsenoside Rh2 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ginsenoside Rh2 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ginsenoside Rh2 GMP manufacturer or Ginsenoside Rh2 GMP API supplier for your needs.
A Ginsenoside Rh2 CoA (Certificate of Analysis) is a formal document that attests to Ginsenoside Rh2's compliance with Ginsenoside Rh2 specifications and serves as a tool for batch-level quality control.
Ginsenoside Rh2 CoA mostly includes findings from lab analyses of a specific batch. For each Ginsenoside Rh2 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ginsenoside Rh2 may be tested according to a variety of international standards, such as European Pharmacopoeia (Ginsenoside Rh2 EP), Ginsenoside Rh2 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ginsenoside Rh2 USP).
